| Product Code: ETC071548 | Publication Date: Jun 2021 | Updated Date: Jun 2026 | Product Type: Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 |
The United Kingdom (UK) Infectious Disease Rapid Diagnostic Testing Market was estimated at USD 191 Million in 2025 and is projected to reach USD 208 Million by 2032, growing at a CAGR of 1.2% from 2026 to 2032. This growth trajectory is primarily fueled by the rising incidence of infectious diseases coupled with an increased emphasis on rapid and reliable diagnostic solutions. The market is further supported by advancements in technology and a growing preference for point-of-care testing, enabling healthcare providers to deliver timely patient care.
This graph highlights how the United Kingdom (UK) Infectious Disease Rapid Diagnostic Testing Market has steadily grown over the years, supported by major growth factors.

The table below presents the year‑wise growth rates along with the key drivers influencing the market
| Year | Growth Rate | Major Drivers |
| 2021 | -3.6% | Increasing industrial infrastructure investments |
| 2022 | 4.9% | Expansion of transportation and logistics networks |
| 2023 | 5.7% | Expansion of manufacturing activities |
| 2024 | 0.5% | Growing renewable energy integration projects |
| 2025 | -0.1% | Government infrastructure modernization initiatives |
| 2026 | 1.4% | Rapid growth in telecom and data center sectors |
| 2027 | 0.8% | Expansion of manufacturing activities |
| 2028 | 2.1% | Expansion of commercial construction activities |
| 2029 | 1.8% | Government infrastructure modernization initiatives |
| 2030 | 2.1% | Increasing adoption of advanced technologies |
| 2031 | 1.3% | Increasing smart city development projects |
| 2032 | 0.9% | Increasing industrial infrastructure investments |
Note - Market size estimations and growth projections presented in this report are based on 6Wresearch’s advanced forecasting approach, validated with industry datasets as of June 2026.
The growing awareness surrounding early disease detection is the foremost force propelling the United Kingdom's rapid diagnostic testing market. As healthcare professionals and patients alike recognize the importance of quick results, the adoption of innovative testing methodologies is accelerating.
Additionally, the ongoing technological advancements in diagnostic testing, such as the integration of molecular testing techniques, are enhancing the market landscape. These innovations not only improve the sensitivity and specificity of tests but also expand the testing capabilities to cover a broader spectrum of infectious diseases.
Despite promising growth, the market faces significant restraints that could impede its momentum. Regulatory challenges surrounding the approval processes for new testing technologies present a formidable barrier to entry. Furthermore, the entrenched competition from established diagnostic methods creates a landscape that requires continuous innovation and improvement. Awareness gaps among healthcare professionals and the public regarding the benefits of rapid testing also slow adoption rates, while cost constraints and reimbursement complexities further complicate widespread implementation.
Current trends in the UK Infectious Disease Rapid Diagnostic Testing Market indicate a shift towards more decentralized and accessible testing methods. The rise of home testing kits and mobile diagnostic technologies is reshaping how patients engage with healthcare services. Concurrently, there is an increased focus on enhancing the accuracy and reliability of tests, especially with the emergence of new pathogens. The demand for rapid diagnostic solutions continues to evolve as more health systems seek to integrate such technologies into routine care.
Investment opportunities in the UK market are abundant, particularly in the realm of point-of-care testing. Innovations such as biosensors and smartphone-based diagnostic tools are increasingly appealing to investors and developers alike. Additionally, partnerships with healthcare providers and research institutions could catalyze advancements, facilitating greater market penetration. The emphasis on timely and effective healthcare solutions underscores the potential for growth in this sector, as stakeholders seek to capitalize on the increasing demand for rapid diagnostic technologies.
The UK government has implemented various initiatives aimed at supporting the development and accessibility of rapid diagnostic testing. These measures include funding for research and development, as well as streamlined regulatory processes that expedite the approval of innovative testing technologies. Furthermore, public health initiatives, particularly in response to past pandemics, have increased the availability of rapid testing in healthcare settings, thereby enhancing national preparedness and improving overall healthcare outcomes.
Looking forward to the period from 2026 to 2032, the UK Infectious Disease Rapid Diagnostic Testing Market is set for notable advancements driven by an increasing focus on early detection and preventive healthcare measures. The demand for rapid diagnostic tests is projected to intensify, particularly for diseases like COVID-19, influenza, and sexually transmitted infections. As the government continues to bolster healthcare infrastructure and promote innovation, the landscape for rapid diagnostic testing will likely evolve, offering new opportunities for both existing and emerging players in the market.
In recent months, the UK Infectious Disease Rapid Diagnostic Testing Market has witnessed significant activity, with several new products launched that focus on improving the speed and accuracy of diagnostics. Additionally, partnerships between technology developers and healthcare providers have strengthened, paving the way for innovations that enhance point-of-care testing capabilities. Public health initiatives continue to adapt, reflecting a commitment to increasing the availability and effectiveness of rapid testing in various healthcare settings.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Infectious Disease Rapid Diagnostic Testing Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, 2022 & 2032F |
3.3 United Kingdom (UK) Infectious Disease Rapid Diagnostic Testing Market - Industry Life Cycle |
3.4 United Kingdom (UK) Infectious Disease Rapid Diagnostic Testing Market - Porter's Five Forces |
3.5 United Kingdom (UK) Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume Share, By Form, 2022 & 2032F |
3.6 United Kingdom (UK) Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume Share, By Technology, 2022 & 2032F |
3.7 United Kingdom (UK) Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume Share, By End-users, 2022 & 2032F |
4 United Kingdom (UK) Infectious Disease Rapid Diagnostic Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases in the UK |
4.2.2 Growing awareness about the importance of early disease detection and management |
4.2.3 Technological advancements in rapid diagnostic testing methods |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for diagnostic tests |
4.3.2 Limited accessibility to advanced diagnostic technologies in certain regions of the UK |
5 United Kingdom (UK) Infectious Disease Rapid Diagnostic Testing Market Trends |
6 United Kingdom (UK) Infectious Disease Rapid Diagnostic Testing Market, By Types |
6.1 United Kingdom (UK) Infectious Disease Rapid Diagnostic Testing Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Product, 2022-2032F |
6.1.3 United Kingdom (UK) Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Assays, Kits and Reagents, 2022-2032F |
6.1.4 United Kingdom (UK) Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Instruments, 2022-2032F |
6.1.5 United Kingdom (UK) Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Services and Software, 2022-2032F |
6.2 United Kingdom (UK) Infectious Disease Rapid Diagnostic Testing Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Immunodiagnostics, 2022-2032F |
6.2.3 United Kingdom (UK) Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Clinical Microbiology, 2022-2032F |
6.2.4 United Kingdom (UK) Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By PCR, 2022-2032F |
6.2.5 United Kingdom (UK) Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By INAAT, 2022-2032F |
6.2.6 United Kingdom (UK) Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By DNA Sequencing and NGS, 2022-2032F |
6.2.7 United Kingdom (UK) Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Other Technologies, 2022-2032F |
6.3 United Kingdom (UK) Infectious Disease Rapid Diagnostic Testing Market, By End-users |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Physician Offices, 2022-2032F |
6.3.3 United Kingdom (UK) Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Reference Laboratories, 2022-2032F |
6.3.4 United Kingdom (UK) Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Hospitals, 2022-2032F |
6.3.5 United Kingdom (UK) Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Academic and Research Institutes, 2022-2032F |
6.3.6 United Kingdom (UK) Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Others, 2022-2032F |
7 United Kingdom (UK) Infectious Disease Rapid Diagnostic Testing Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Infectious Disease Rapid Diagnostic Testing Market Export to Major Countries |
7.2 United Kingdom (UK) Infectious Disease Rapid Diagnostic Testing Market Imports from Major Countries |
8 United Kingdom (UK) Infectious Disease Rapid Diagnostic Testing Market Key Performance Indicators |
8.1 Adoption rate of rapid diagnostic testing by healthcare facilities |
8.2 Rate of integration of rapid diagnostic testing in routine clinical practice |
8.3 Number of partnerships between diagnostic test manufacturers and healthcare providers for promoting rapid testing technologies |
9 United Kingdom (UK) Infectious Disease Rapid Diagnostic Testing Market - Opportunity Assessment |
9.1 United Kingdom (UK) Infectious Disease Rapid Diagnostic Testing Market Opportunity Assessment, By Product, 2022 & 2032F |
9.2 United Kingdom (UK) Infectious Disease Rapid Diagnostic Testing Market Opportunity Assessment, By Technology, 2022 & 2032F |
9.3 United Kingdom (UK) Infectious Disease Rapid Diagnostic Testing Market Opportunity Assessment, By End-users, 2022 & 2032F |
10 United Kingdom (UK) Infectious Disease Rapid Diagnostic Testing Market - Competitive Landscape |
10.1 United Kingdom (UK) Infectious Disease Rapid Diagnostic Testing Market Revenue Share, By Companies, 2025 |
10.2 United Kingdom (UK) Infectious Disease Rapid Diagnostic Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here